Loading…

Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats

The effects of the phenolic compounds butylated hydroxytoluene (BHT), sesamin (S), curcumin (CU), and ferulic acid (FA) on plasma, liver, and lung concentrations of α‐ and γ‐tocopherols (T), on plasma and liver cholesterol, and on the fatty acid composition of liver lipids were studied in male Sprag...

Full description

Saved in:
Bibliographic Details
Published in:Lipids 2000-04, Vol.35 (4), p.427-435
Main Authors: Kamal-Eldin, A, Frank, J, Razdan, A, Tengblad, S, Basu, S, Vessby, B
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4597-c46b4e00396e2fbc4ff9b44ddedc2508366f1b07e2394a125ce279d2a207e0fe3
cites cdi_FETCH-LOGICAL-c4597-c46b4e00396e2fbc4ff9b44ddedc2508366f1b07e2394a125ce279d2a207e0fe3
container_end_page 435
container_issue 4
container_start_page 427
container_title Lipids
container_volume 35
creator Kamal-Eldin, A
Frank, J
Razdan, A
Tengblad, S
Basu, S
Vessby, B
description The effects of the phenolic compounds butylated hydroxytoluene (BHT), sesamin (S), curcumin (CU), and ferulic acid (FA) on plasma, liver, and lung concentrations of α‐ and γ‐tocopherols (T), on plasma and liver cholesterol, and on the fatty acid composition of liver lipids were studied in male Sprague‐Dawley rats. Test compounds were given to rats ad libitum for 4 wk at 4 g/kg diet, in a diet low but adequate in vitamin E (36 mg/kg of γ‐T and 25 mg/kg of α‐T) and containing 2 g/kg of cholesterol. BHT significantly reduced feed intake (P
doi_str_mv 10.1007/s11745-000-541-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71191955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2446677901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4597-c46b4e00396e2fbc4ff9b44ddedc2508366f1b07e2394a125ce279d2a207e0fe3</originalsourceid><addsrcrecordid>eNqFkb9P3TAQx60KVF5p906txdCJ0POvxB4RUEB6EkgtQyfLcewSlBc_7EQo_32vCkPVpYut832-p9PHhHxkcMYAmq-FsUaqCgAqJVm1vCEbppSujIDmgGwAuKwkB3ZE3pXyhCWTRr0lRwy00sD1hvy8ijH4qdAUadeHyeWF7h_DmIbeU592-zSPHXZHOiWfsJPTcEr9YxpCmdbCjR2NbpoW6nyPbD_S7KbynhxGN5Tw4fU-Jg_frn5c3FTbu-vbi_Nt5aUyDZ51KwOAMHXgsfUyRtNK2XWh81yBFnUdWQtN4MJIx7jygTem447jG8QgjsmXde4-p-cZt7K7vvgwDG4MaS62YcwwoxSCJ_-AT2nOI-5mtdZMSM45QrBCPqdScoh2n_sdWrEM7B_ndnVu0blF53bByKfXuXO7C91fgVUyAvUKvPRDWP470G5v7y9B8gaDn9dgdMm6X7kv9uE7fqcAbpTQCsRvCM2WJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>888134222</pqid></control><display><type>article</type><title>Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats</title><source>Wiley</source><source>SpringerLink Journals</source><creator>Kamal-Eldin, A ; Frank, J ; Razdan, A ; Tengblad, S ; Basu, S ; Vessby, B</creator><creatorcontrib>Kamal-Eldin, A ; Frank, J ; Razdan, A ; Tengblad, S ; Basu, S ; Vessby, B</creatorcontrib><description><![CDATA[The effects of the phenolic compounds butylated hydroxytoluene (BHT), sesamin (S), curcumin (CU), and ferulic acid (FA) on plasma, liver, and lung concentrations of α‐ and γ‐tocopherols (T), on plasma and liver cholesterol, and on the fatty acid composition of liver lipids were studied in male Sprague‐Dawley rats. Test compounds were given to rats ad libitum for 4 wk at 4 g/kg diet, in a diet low but adequate in vitamin E (36 mg/kg of γ‐T and 25 mg/kg of α‐T) and containing 2 g/kg of cholesterol. BHT significantly reduced feed intake (P<0.05) and body weight and increased feed conversion ratio; S and BHT caused a significant enlargement of the liver (P<0.001), whereas CU and FA did not affect any of these parameters. The amount of liver lipids was significantly lowered by BHT (P<0.01) while the other substances reduced liver lipid concentrations but not significantly. Regarding effects on tocopherol levels, (i) feeding of BHT resulted in a significant elevation (P<0.001) of α‐T in plasma, liver, and lung, while γ‐T values remained unchanged; (ii) rats provided with the S diet had substantially higher γ‐T levels (P<0.001) in plasma, liver, and lung, whereas α‐T levels were not affected; (iii) administration of CU raised the concentration of α‐T in the lung (P<0.01) but did not affect the plasma or liver values of any of the tocopherols; and (iv) FA had no effect on the levels of either homolog in the plasma, liver, or lung. The level of an unknown substance in the liver was significantly reduced by dietary BHT (P<0.001). BHT was the only compound that tended to increase total cholesterol (TC) in plasma, due to an elevation of cholesterol in the very low density lipoprotein + low density lipoprotein (VLDL+LDL) fraction. S and FA tended to lower plasma total and VLDL+LDL cholesterol concentrations, but the effect for CU was statistically significant (P<0.05). FA increased plasma high density lipoprotein cholesterol while the other compounds reduced it numerially, but not significantly. BHT, CU, and S reduced cholesterol levels in the liver TC (P<0.001) and percentages of TC in liver lipids (P<0.05). With regard to the fatty acid composition of liver lipids, S increased the n‐6/n‐3 and the 18∶3/20∶5 polyunsaturated fatty acids (PUFA) ratios, and BHT lowered total monounsaturated fatty acids and increased total PUFA (n−6+n−3). The effects of CU and FA on fatty acids were not highly significant. These results suggest some in vivo interactions between these phenolic compounds and tocopherols that may increase the bioavailability of vitamin E and decrease cholesterol in rats.]]></description><identifier>ISSN: 0024-4201</identifier><identifier>EISSN: 1558-9307</identifier><identifier>DOI: 10.1007/s11745-000-541-y</identifier><identifier>PMID: 10858028</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer‐Verlag</publisher><subject>Animals ; Bioavailability ; Body weight ; Butylated Hydroxytoluene - pharmacology ; Cholesterol ; Cholesterol - blood ; Cholesterol - metabolism ; Cholesterol, HDL - blood ; Cholesterol, LDL - blood ; Cholesterol, VLDL - blood ; Coumaric Acids - pharmacology ; Curcumin - pharmacology ; Diet ; diet-related diseases ; Dioxoles - pharmacology ; Fatty acids ; Fatty Acids - metabolism ; Feed conversion ; human nutrition ; Lignans - pharmacology ; Lipids ; Liver ; Liver - metabolism ; Low density lipoprotein ; Lung - metabolism ; Male ; Nutrition ; nutrition physiology ; Phenols ; Phenols - administration &amp; dosage ; Phenols - pharmacology ; Polyunsaturated fatty acids ; Rats ; Rats, Sprague-Dawley ; Vitamin E - blood ; Vitamin E - metabolism</subject><ispartof>Lipids, 2000-04, Vol.35 (4), p.427-435</ispartof><rights>2000 American Oil Chemists' Society (AOCS)</rights><rights>AOCS Press 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4597-c46b4e00396e2fbc4ff9b44ddedc2508366f1b07e2394a125ce279d2a207e0fe3</citedby><cites>FETCH-LOGICAL-c4597-c46b4e00396e2fbc4ff9b44ddedc2508366f1b07e2394a125ce279d2a207e0fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1643,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10858028$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kamal-Eldin, A</creatorcontrib><creatorcontrib>Frank, J</creatorcontrib><creatorcontrib>Razdan, A</creatorcontrib><creatorcontrib>Tengblad, S</creatorcontrib><creatorcontrib>Basu, S</creatorcontrib><creatorcontrib>Vessby, B</creatorcontrib><title>Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats</title><title>Lipids</title><addtitle>Lipids</addtitle><description><![CDATA[The effects of the phenolic compounds butylated hydroxytoluene (BHT), sesamin (S), curcumin (CU), and ferulic acid (FA) on plasma, liver, and lung concentrations of α‐ and γ‐tocopherols (T), on plasma and liver cholesterol, and on the fatty acid composition of liver lipids were studied in male Sprague‐Dawley rats. Test compounds were given to rats ad libitum for 4 wk at 4 g/kg diet, in a diet low but adequate in vitamin E (36 mg/kg of γ‐T and 25 mg/kg of α‐T) and containing 2 g/kg of cholesterol. BHT significantly reduced feed intake (P<0.05) and body weight and increased feed conversion ratio; S and BHT caused a significant enlargement of the liver (P<0.001), whereas CU and FA did not affect any of these parameters. The amount of liver lipids was significantly lowered by BHT (P<0.01) while the other substances reduced liver lipid concentrations but not significantly. Regarding effects on tocopherol levels, (i) feeding of BHT resulted in a significant elevation (P<0.001) of α‐T in plasma, liver, and lung, while γ‐T values remained unchanged; (ii) rats provided with the S diet had substantially higher γ‐T levels (P<0.001) in plasma, liver, and lung, whereas α‐T levels were not affected; (iii) administration of CU raised the concentration of α‐T in the lung (P<0.01) but did not affect the plasma or liver values of any of the tocopherols; and (iv) FA had no effect on the levels of either homolog in the plasma, liver, or lung. The level of an unknown substance in the liver was significantly reduced by dietary BHT (P<0.001). BHT was the only compound that tended to increase total cholesterol (TC) in plasma, due to an elevation of cholesterol in the very low density lipoprotein + low density lipoprotein (VLDL+LDL) fraction. S and FA tended to lower plasma total and VLDL+LDL cholesterol concentrations, but the effect for CU was statistically significant (P<0.05). FA increased plasma high density lipoprotein cholesterol while the other compounds reduced it numerially, but not significantly. BHT, CU, and S reduced cholesterol levels in the liver TC (P<0.001) and percentages of TC in liver lipids (P<0.05). With regard to the fatty acid composition of liver lipids, S increased the n‐6/n‐3 and the 18∶3/20∶5 polyunsaturated fatty acids (PUFA) ratios, and BHT lowered total monounsaturated fatty acids and increased total PUFA (n−6+n−3). The effects of CU and FA on fatty acids were not highly significant. These results suggest some in vivo interactions between these phenolic compounds and tocopherols that may increase the bioavailability of vitamin E and decrease cholesterol in rats.]]></description><subject>Animals</subject><subject>Bioavailability</subject><subject>Body weight</subject><subject>Butylated Hydroxytoluene - pharmacology</subject><subject>Cholesterol</subject><subject>Cholesterol - blood</subject><subject>Cholesterol - metabolism</subject><subject>Cholesterol, HDL - blood</subject><subject>Cholesterol, LDL - blood</subject><subject>Cholesterol, VLDL - blood</subject><subject>Coumaric Acids - pharmacology</subject><subject>Curcumin - pharmacology</subject><subject>Diet</subject><subject>diet-related diseases</subject><subject>Dioxoles - pharmacology</subject><subject>Fatty acids</subject><subject>Fatty Acids - metabolism</subject><subject>Feed conversion</subject><subject>human nutrition</subject><subject>Lignans - pharmacology</subject><subject>Lipids</subject><subject>Liver</subject><subject>Liver - metabolism</subject><subject>Low density lipoprotein</subject><subject>Lung - metabolism</subject><subject>Male</subject><subject>Nutrition</subject><subject>nutrition physiology</subject><subject>Phenols</subject><subject>Phenols - administration &amp; dosage</subject><subject>Phenols - pharmacology</subject><subject>Polyunsaturated fatty acids</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Vitamin E - blood</subject><subject>Vitamin E - metabolism</subject><issn>0024-4201</issn><issn>1558-9307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNqFkb9P3TAQx60KVF5p906txdCJ0POvxB4RUEB6EkgtQyfLcewSlBc_7EQo_32vCkPVpYut832-p9PHhHxkcMYAmq-FsUaqCgAqJVm1vCEbppSujIDmgGwAuKwkB3ZE3pXyhCWTRr0lRwy00sD1hvy8ijH4qdAUadeHyeWF7h_DmIbeU592-zSPHXZHOiWfsJPTcEr9YxpCmdbCjR2NbpoW6nyPbD_S7KbynhxGN5Tw4fU-Jg_frn5c3FTbu-vbi_Nt5aUyDZ51KwOAMHXgsfUyRtNK2XWh81yBFnUdWQtN4MJIx7jygTem447jG8QgjsmXde4-p-cZt7K7vvgwDG4MaS62YcwwoxSCJ_-AT2nOI-5mtdZMSM45QrBCPqdScoh2n_sdWrEM7B_ndnVu0blF53bByKfXuXO7C91fgVUyAvUKvPRDWP470G5v7y9B8gaDn9dgdMm6X7kv9uE7fqcAbpTQCsRvCM2WJQ</recordid><startdate>200004</startdate><enddate>200004</enddate><creator>Kamal-Eldin, A</creator><creator>Frank, J</creator><creator>Razdan, A</creator><creator>Tengblad, S</creator><creator>Basu, S</creator><creator>Vessby, B</creator><general>Springer‐Verlag</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PCBAR</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200004</creationdate><title>Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats</title><author>Kamal-Eldin, A ; Frank, J ; Razdan, A ; Tengblad, S ; Basu, S ; Vessby, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4597-c46b4e00396e2fbc4ff9b44ddedc2508366f1b07e2394a125ce279d2a207e0fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Bioavailability</topic><topic>Body weight</topic><topic>Butylated Hydroxytoluene - pharmacology</topic><topic>Cholesterol</topic><topic>Cholesterol - blood</topic><topic>Cholesterol - metabolism</topic><topic>Cholesterol, HDL - blood</topic><topic>Cholesterol, LDL - blood</topic><topic>Cholesterol, VLDL - blood</topic><topic>Coumaric Acids - pharmacology</topic><topic>Curcumin - pharmacology</topic><topic>Diet</topic><topic>diet-related diseases</topic><topic>Dioxoles - pharmacology</topic><topic>Fatty acids</topic><topic>Fatty Acids - metabolism</topic><topic>Feed conversion</topic><topic>human nutrition</topic><topic>Lignans - pharmacology</topic><topic>Lipids</topic><topic>Liver</topic><topic>Liver - metabolism</topic><topic>Low density lipoprotein</topic><topic>Lung - metabolism</topic><topic>Male</topic><topic>Nutrition</topic><topic>nutrition physiology</topic><topic>Phenols</topic><topic>Phenols - administration &amp; dosage</topic><topic>Phenols - pharmacology</topic><topic>Polyunsaturated fatty acids</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Vitamin E - blood</topic><topic>Vitamin E - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamal-Eldin, A</creatorcontrib><creatorcontrib>Frank, J</creatorcontrib><creatorcontrib>Razdan, A</creatorcontrib><creatorcontrib>Tengblad, S</creatorcontrib><creatorcontrib>Basu, S</creatorcontrib><creatorcontrib>Vessby, B</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Lipids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamal-Eldin, A</au><au>Frank, J</au><au>Razdan, A</au><au>Tengblad, S</au><au>Basu, S</au><au>Vessby, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats</atitle><jtitle>Lipids</jtitle><addtitle>Lipids</addtitle><date>2000-04</date><risdate>2000</risdate><volume>35</volume><issue>4</issue><spage>427</spage><epage>435</epage><pages>427-435</pages><issn>0024-4201</issn><eissn>1558-9307</eissn><abstract><![CDATA[The effects of the phenolic compounds butylated hydroxytoluene (BHT), sesamin (S), curcumin (CU), and ferulic acid (FA) on plasma, liver, and lung concentrations of α‐ and γ‐tocopherols (T), on plasma and liver cholesterol, and on the fatty acid composition of liver lipids were studied in male Sprague‐Dawley rats. Test compounds were given to rats ad libitum for 4 wk at 4 g/kg diet, in a diet low but adequate in vitamin E (36 mg/kg of γ‐T and 25 mg/kg of α‐T) and containing 2 g/kg of cholesterol. BHT significantly reduced feed intake (P<0.05) and body weight and increased feed conversion ratio; S and BHT caused a significant enlargement of the liver (P<0.001), whereas CU and FA did not affect any of these parameters. The amount of liver lipids was significantly lowered by BHT (P<0.01) while the other substances reduced liver lipid concentrations but not significantly. Regarding effects on tocopherol levels, (i) feeding of BHT resulted in a significant elevation (P<0.001) of α‐T in plasma, liver, and lung, while γ‐T values remained unchanged; (ii) rats provided with the S diet had substantially higher γ‐T levels (P<0.001) in plasma, liver, and lung, whereas α‐T levels were not affected; (iii) administration of CU raised the concentration of α‐T in the lung (P<0.01) but did not affect the plasma or liver values of any of the tocopherols; and (iv) FA had no effect on the levels of either homolog in the plasma, liver, or lung. The level of an unknown substance in the liver was significantly reduced by dietary BHT (P<0.001). BHT was the only compound that tended to increase total cholesterol (TC) in plasma, due to an elevation of cholesterol in the very low density lipoprotein + low density lipoprotein (VLDL+LDL) fraction. S and FA tended to lower plasma total and VLDL+LDL cholesterol concentrations, but the effect for CU was statistically significant (P<0.05). FA increased plasma high density lipoprotein cholesterol while the other compounds reduced it numerially, but not significantly. BHT, CU, and S reduced cholesterol levels in the liver TC (P<0.001) and percentages of TC in liver lipids (P<0.05). With regard to the fatty acid composition of liver lipids, S increased the n‐6/n‐3 and the 18∶3/20∶5 polyunsaturated fatty acids (PUFA) ratios, and BHT lowered total monounsaturated fatty acids and increased total PUFA (n−6+n−3). The effects of CU and FA on fatty acids were not highly significant. These results suggest some in vivo interactions between these phenolic compounds and tocopherols that may increase the bioavailability of vitamin E and decrease cholesterol in rats.]]></abstract><cop>Berlin/Heidelberg</cop><pub>Springer‐Verlag</pub><pmid>10858028</pmid><doi>10.1007/s11745-000-541-y</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-4201
ispartof Lipids, 2000-04, Vol.35 (4), p.427-435
issn 0024-4201
1558-9307
language eng
recordid cdi_proquest_miscellaneous_71191955
source Wiley; SpringerLink Journals
subjects Animals
Bioavailability
Body weight
Butylated Hydroxytoluene - pharmacology
Cholesterol
Cholesterol - blood
Cholesterol - metabolism
Cholesterol, HDL - blood
Cholesterol, LDL - blood
Cholesterol, VLDL - blood
Coumaric Acids - pharmacology
Curcumin - pharmacology
Diet
diet-related diseases
Dioxoles - pharmacology
Fatty acids
Fatty Acids - metabolism
Feed conversion
human nutrition
Lignans - pharmacology
Lipids
Liver
Liver - metabolism
Low density lipoprotein
Lung - metabolism
Male
Nutrition
nutrition physiology
Phenols
Phenols - administration & dosage
Phenols - pharmacology
Polyunsaturated fatty acids
Rats
Rats, Sprague-Dawley
Vitamin E - blood
Vitamin E - metabolism
title Effects of dietary phenolic compounds on tocopherol, cholesterol, and fatty acids in rats
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T01%3A12%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20dietary%20phenolic%20compounds%20on%20tocopherol,%20cholesterol,%20and%20fatty%20acids%20in%20rats&rft.jtitle=Lipids&rft.au=Kamal-Eldin,%20A&rft.date=2000-04&rft.volume=35&rft.issue=4&rft.spage=427&rft.epage=435&rft.pages=427-435&rft.issn=0024-4201&rft.eissn=1558-9307&rft_id=info:doi/10.1007/s11745-000-541-y&rft_dat=%3Cproquest_cross%3E2446677901%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4597-c46b4e00396e2fbc4ff9b44ddedc2508366f1b07e2394a125ce279d2a207e0fe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=888134222&rft_id=info:pmid/10858028&rfr_iscdi=true